Inventor · disambiguated record
Jennifer Busby
Also filed as: BUSBY JENNIFER
5 granted patents·19 pending applications·24 citations·filing 2016–2025
74Inventor score
Top patents by PatentIndex Score
24 records- 0193US11183286B2Neoantigen identification, manufacture, and useGRITSTONE BIO INC·Filed 2020·Granted Nov 23, 2021·3 cites·30 claims
- 0291US10055540B2Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2017·Granted Aug 21, 2018·21 cites·25 claims
- 0373US2024361335A1Reducing junction epitope presentation for neoantigensGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 0471US2024067985A1Viral delivery of neoantigensGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 0569US2025316334A1Neoantigen identification, manufacture, and useGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 0668US2023382997A1Antigen-binding proteins targeting shared antigensGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 0768US2025270589A1Viral delivery of neoantigensSEATTLE PROJECT CORP·Filed 2025·Application pending·0 cites
- 0866US10847253B2Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Granted Nov 24, 2020·0 cites·30 claims
- 0965US10847252B2Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Granted Nov 24, 2020·0 cites·31 claims
- 1060US2019034585A1Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 1159US11885815B2Reducing junction epitope presentation for neoantigensGRITSTONE BIO INC·Filed 2018·Granted Jan 30, 2024·0 cites·9 claims
- 1258US2023020089A1Shared neoantigen vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1358US2023041030A1Antigen-binding proteins targeting shared neoantigensGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1455US2017199961A1Neoantigen Identification, Manufacture, and UseGRITSTONE ONCOLOGY INC·Filed 2016·Application pending·0 cites
- 1554US2021113673A1Neoantigen Identification, Manufacture, and UseGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 1652US2021147550A1Antigen-binding proteins targeting shared antigensFRANCIS JOSHUA MICHAEL·Filed 2018·Application pending·0 cites
- 1748US2020010849A1Viral delivery of neoantigensGRITSTONE ONCOLOGY INC·Filed 2017·Application pending·0 cites
- 1848US2022213196A1Antigen-binding proteins targeting shared antigensGRITSTONE BIO INC·Filed 2019·Application pending·0 cites
- 1947US2021196806A1Shared antigensGRITSTONE ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2042US2020411135A1Neoantigen Identification with Pan-Allele ModelsGRITSTONE ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2141US2022154281A1Identification of neoantigens with mhc class ii modelGRITSTONE BIO INC·Filed 2020·Application pending·0 cites
- 2240US2020105377A1Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 2338US2021061914A1Antigen-Binding Proteins Targeting Shared AntigensGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 2433US2020363414A1Neoantigen Identification for T-Cell TherapyGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →